The potential protective role of Parkinson's disease against hypothyroidism: co-localisation and bidirectional Mendelian randomization study

Front Aging Neurosci. 2024 May 14:16:1377719. doi: 10.3389/fnagi.2024.1377719. eCollection 2024.

Abstract

Background: The association between hypothyroidism and Parkinson's disease (PD) has sparked intense debate in the medical community due to conflicting study results. A better understanding of this association is crucial because of its potential implications for both pathogenesis and treatment strategies.

Methods: To elucidate this complex relationship, we used Bayesian co-localisation (COLOC) and bidirectional Mendelian randomization (MR) analysis. COLOC was first used to determine whether hypothyroidism and PD share a common genetic basis. Subsequently, genetic variants served as instrumental variables in a bidirectional MR to explore causal interactions between these conditions.

Results: COLOC analysis revealed no shared genetic variants between hypothyroidism and PD, with a posteriori probability of hypothesis 4 (PPH4) = 0.025. Furthermore, MR analysis indicated that hypothyroidism does not have a substantial causal effect on PD (OR = 0.990, 95% CI = 0.925, 1.060, p = 0.774). Conversely, PD appears to have a negative causal effect on hypothyroidism (OR = 0.776, 95% CI = 0.649, 0.928, p = 0.005).

Conclusion: Our findings suggest the absence of shared genetic variants between hypothyroidism and PD. Interestingly, PD may inversely influence the risk of developing hypothyroidism, a finding that may inform future research and clinical approaches.

Keywords: Mendelian randomization; Parkinson’s disease; co-localization; hypothyroidism; single-nucleotide polymorphism.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research received funding from the National Natural Science Foundation of China, under Grant/Award Numbers 81801268 and 82060248. Additionally, it was supported by the Clinical Research “Climbing” Program of the First Affiliated Hospital of Guangxi Medical University, Grant/Award Number YYZS2020017. This study was also funded by First-class discipline innovation-driven talentprogram of Guangxi Medical University.